This transition involves the discontinuation of current formulations of VicodinÂ®, and a new distribution of the reformulated medication with a safer dosing of APAP. What does this mean for you? Abbott, the makers of Vicodin, have already discontinued the manufacturing of the current (pre June 2012) formulation. This does not mean that it will be immediately unavailable, but it does mean that prescribers will be declining their issuance of the pre June 2012 formulation. Replacement therapies will include: